Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-11-001590
Filing Date
2011-03-01
Accepted
2011-03-01 09:00:49
Documents
8
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2202313z10-k.htm 10-K 1028563
2 EX-10.23 a2202313zex-10_23.htm EX-10.23 81632
3 EX-10.24 a2202313zex-10_24.htm EX-10.24 181206
4 EX-23.1 a2202313zex-23_1.htm EX-23.1 5772
5 EX-31.1 a2202313zex-31_1.htm EX-31.1 7937
6 EX-31.2 a2202313zex-31_2.htm EX-31.2 7969
7 EX-32.1 a2202313zex-32_1.htm EX-32.1 5290
8 G279495.JPG g279495.jpg GRAPHIC 38003
  Complete submission text file 0001047469-11-001590.txt   1372325
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29889 | Film No.: 11649145
SIC: 2834 Pharmaceutical Preparations